Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$441M |
| 2 |
Broadcom
AVGO
|
+$328M |
| 3 |
Pfizer
PFE
|
+$292M |
| 4 |
Tesla
TSLA
|
+$252M |
| 5 |
IBM
IBM
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares National Muni Bond ETF
MUB
|
+$295M |
| 2 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$138M |
| 3 |
General Mills
GIS
|
+$131M |
| 4 |
Chevron
CVX
|
+$116M |
| 5 |
PPG Industries
PPG
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.91% |
| 2 | Financials | 13.22% |
| 3 | Healthcare | 13.19% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MYOV
2351
DELISTED
Myovant Sciences Ltd.
MYOV
| $3.91M | ﹤0.01% |
217,666
-5,056
| -2% | -$80.7K |
|
|
AGEN
2352
Agenus
AGEN
$326M
| $3.91M | ﹤0.01% |
97,088
+4,305
| +5% | +$220K |
|
2353
Portillo's
PTLO
$329M
| $3.88M | ﹤0.01% |
197,242
+50,590
| +34% | +$1.11M |
|
2354
Bionano Genomics
BNGO
$12.7M
| $3.88M | ﹤0.01% |
3,533
+60
| +2% | +$79.3K |
|
2355
Fluence Energy
FLNC
$1.93B
| $3.87M | ﹤0.01% |
265,028
+18,107
| +7% | +$273K |
|
2356
Health Catalyst
HCAT
$163M
| $3.86M | ﹤0.01% |
398,060
+11,454
| +3% | +$152K |
|
|
PAYA
2357
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
| $3.86M | ﹤0.01% |
631,844
+31,123
| +5% | +$205K |
|
|
STEL
2358
DELISTED
Stellar Bancorp
STEL
| $3.83M | ﹤0.01% |
131,085
-251
| -0.2% | -$7.55K |
|
|
DICE
2359
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $3.83M | ﹤0.01% |
188,676
+64,871
| +52% | +$1.18M |
|
|
VRAY
2360
DELISTED
ViewRay, Inc.
VRAY
| $3.82M | ﹤0.01% |
1,050,180
-55,880
| -5% | -$187K |
|
|
RUTH
2361
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $3.82M | ﹤0.01% |
226,508
+3,981
| +2% | +$70.5K |
|
2362
VanEck High Yield Muni ETF
HYD
$4.42B
| $3.82M | ﹤0.01% |
76,464
-24,584
| -24% | -$1.31M |
|
2363
Rocket Companies
RKT
$38.7B
| $3.81M | ﹤0.01% |
603,226
+5,667
| +0.9% | +$49.3K |
|
2364
Sana Biotechnology
SANA
$885M
| $3.81M | ﹤0.01% |
634,869
+35,244
| +6% | +$254K |
|
|
ACLX
2365
DELISTED
Arcellx
ACLX
| $3.81M | ﹤0.01% |
202,839
+136,937
| +208% | +$2.62M |
|
|
VZIO
2366
DELISTED
VIZIO Holding Corp.
VZIO
| $3.79M | ﹤0.01% |
433,847
+98,649
| +29% | +$992K |
|
|
EGRX
2367
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $3.78M | ﹤0.01% |
143,124
+20,630
| +17% | +$757K |
|
2368
Ennis
EBF
$558M
| $3.76M | ﹤0.01% |
186,964
+5,158
| +3% | +$109K |
|
2369
Merchants Bancorp
MBIN
$2.56B
| $3.76M | ﹤0.01% |
163,131
+4,531
| +3% | +$116K |
|
2370
Fossil Group
FOSL
$348M
| $3.76M | ﹤0.01% |
1,098,179
+136,657
| +14% | +$701K |
|
2371
Design Therapeutics
DSGN
$797M
| $3.75M | ﹤0.01% |
224,560
+89,785
| +67% | +$1.79M |
|
|
DHIL
2372
DELISTED
Diamond Hill
DHIL
| $3.74M | ﹤0.01% |
22,683
+385
| +2% | +$68.2K |
|
2373
HealthStream
HSTM
$828M
| $3.74M | ﹤0.01% |
175,794
+5,020
| +3% | +$114K |
|
2374
OneSpaWorld
OSW
$2.68B
| $3.74M | ﹤0.01% |
444,967
+22
| +0% | +$184 |
|
2375
Insteel Industries
IIIN
$602M
| $3.73M | ﹤0.01% |
140,750
+5,541
| +4% | +$172K |
|
Similar funds
Charles Schwab's Q3 2022 Portfolio in Review
As of Q3 2022, Charles Schwab held 3,614 positions worth $279B, down 2.9% from $287B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab deployed $8.77B of net new capital in Q3 2022, opening 79 new positions and adding to 2,461 existing holdings. Its largest new stake was JPMorgan Ultra-Short Income ETF: 2,974,316 shares worth $149M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares National Muni Bond ETF, an estimated $295M trimmed.
- Charles Schwab's largest Q3 2022 buy was JPMorgan Ultra-Short Income ETF: 2,974,316 shares worth $149M.
- Charles Schwab added most to Verizon in Q3 2022, an estimated $441M increase.
- Charles Schwab's biggest Q3 2022 reduction was iShares National Muni Bond ETF, cutting an estimated $295M.
- Charles Schwab fully exited American Campus Communities, Inc. in Q3 2022, selling an estimated $91.4M.
- Charles Schwab's ten largest holdings make up 17% of its $279B portfolio in Q3 2022.
- Charles Schwab opened 79 new positions and closed 105 in Q3 2022.
- Charles Schwab's portfolio value fell 2.9% quarter-over-quarter to $279B.
Based on Charles Schwab's 13F filing for Q3 2022, filed 14 Nov 2022.